#BEGIN_DRUGCARD DB03151

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
33730

# Chemical_Formula:
Cu4S

# Chemical_IUPAC_Name:
(2r,4s)-1$l^{4}-thia-2,3,4,5-tetracuprapentacyclo[2.1.0.0^{1,3}.0^{2,4}.0^{2,5}]pentane

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(Mu-4-Sulfido)-Tetra-Nuclear Copper Ion

# HET_ID:
CUZ

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/4Cu.S

# InChI_Key:
InChIKey=IGIWMDIIFLPFOP-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3151

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
286.249

# Molecular_Weight_Mono:
283.690475006

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QNI

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0

# Predicted_LogS:
0

# Predicted_Water_Solubility:
Not Available

# Primary_Accession_No:
DB03151

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
4628301

# PubChem_Substance_ID:
46506399

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01060

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[Cu]12[S@]34[Cu]5[Cu@]13[Cu@]245

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:58 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Involved in copper ion binding

# Drug_Target_1_General_References:
10700275	Brown K, Tegoni M, Prudencio M, Pereira AS, Besson S, Moura JJ, Moura I, Cambillau C: A novel type of catalytic copper cluster in nitrous oxide reductase. Nat Struct Biol. 2000 Mar;7(3):191-5.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5124

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
65151

# Drug_Target_1_Name:
Oxidoreductase

# Drug_Target_1_Number_of_Residues:
581

# Drug_Target_1_PDB_ID:
1QNI

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00116	COX2

# Drug_Target_1_Protein_Sequence:
>Oxidoreductase
AAAEEARNKAHVAPGELDEYYGFWSGGHQGEVRVLGVPSMRELMRIPVFNVDSATGWGIT
NESKEILGGDQQYLNGDCHHPHISMTDGRYDGKYLFINDKANTRVARIRLDIMKTDKITH
IPNVQAIHGLRLQKVPKTNYVFCNAEFVIPQPNDGTDFSLDNSYTMFTAIDAETMDVAWQ
VIVDGNLDNTDADYTGKYATSTCYNSERAVDLAGTMRNDRDWVVVFNVERIAAAVKAGNF
KTIGDSKVPVVDGRGESEFTRYIPVPKNPHGLNTSPDGKYFIANGKLSPTVSVIAIDKLD
DLFEDKIELRDTIVAEPELGLGPLHTTFDGRGNAYTTLFIDSQVCKWNIADAIKHYNGDR
VNYIRQKLDVQYQPGHNHASLTESRDADGKWLVVLSKFSKDRFLPVGPLHPENDQLIDIS
GEEMKLVHDGPTYAEPHDCILVRRDQIKTKKIYERNDPYFASCRAQAEKDGVTLESDNKV
IRDGNKVRVYMTSVAPQYGMTDFKVKEGDEVTVYITNLDMVEDVTHGFCMVNHGVSMEIS
PQQTASVTFTAGKPGVYWYYCNWFCHALHMEMVGRMLVEAA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q7SIA3

# Drug_Target_1_SwissProt_Name:
Q7SIA3_MARHY

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
5.37

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Periplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X74792

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
nosZ

# Drug_Target_2_Gene_Sequence:
>1959 bp
ATGGAATCGAAACAGGAAAAGGGTCTCAGCCGCCGCGCGCTTTTGGGCGCGACAGCCGGG
GGCGCGGCCGTGGCCGGCGCGTTCGGCGGACGGCTGGCGCTGGGGCCGGCGGCGCTCGGC
CTGGGCACGGCGGGGGTCGCGACCGTCGCCGGCAGTGGTGCGGCGCTGGCCGCCAGCGGC
GACGGCTCGGTCGCGCCGGGGCAACTGGACGACTACTACGGCTTCTGGTCCTCGGGCCAG
AGCGGCGAGATGCGCATCCTTGGCATTCCCTCGATGCGCGAGCTGATGCGGGTTCCGGTC
TTCAACCGCTGCTCGGCCACCGGCTGGGGCCAGACCAACGAATCCGTGCGCATCCATGAG
CGCACCATGAGCGAGCGGACGAAGAAGTTCCTTGCCGCCAATGGCAAGCGCATCCACGAC
AACGGCGACCTGCACCACGTCCACATGTCCTTTACCGAGGGCAAATATGACGGCCGCTTC
CTGTTCATGAACGACAAGGCCAATACCCGCGTGGCGCGGGTGCGCTGCGACGTGATGAAA
TGCGACGCCATCCTGGAGATCCCCAACGCCAAGGGCATCCACGGCCTGCGGCCGCAGAAA
TGGCCGCGCAGCAACTATGTCTTCTGCAATGGCGAGGACGAGACGCCGCTGGTCAACGAC
GGCACCAACATGGAGGACGTGGCGAATTACGTGAACGTCTTCACCGCCGTCGATGCCGAC
AAGTGGGAGGTCGCCTGGCAGGTGCTCGTCTCGGGCAACCTGGACAACTGCGATGCCGAT
TACGAGGGCAAATGGGCCTTTTCGACCTCCTACAACTCGGAAAAGGGGATGACCCTGCCC
GAGATGACGGCGGCCGAGATGGACCATATCGTCGTCTTCAACATCGCCGAGATCGAAAAG
GCCATCGCTGCCGGCGACTATCAGGAACTGAACGGCGTCAAGGTCGTGGATGGCCGGAAA
GAGGCAAGCAGCCTGTTCACCCGCTATATCCCCATCGCCAACAACCCGCATGGCTGCAAC
ATGGCGCCGGACAAGAAGCACCTGTGCGTCGCGGGCAAGCTGTCGCCCACGGCGACGGTG
CTGGACGTGACCCGGTTCGACGCGGTGTTCTATGAGAACGCCGATCCGCGCAGCGCCGTG
GTGGCCGAGCCGGAACTGGGCCTTGGCCCGCTGCACACCGCCTTCGACGGGCGCGGCAAC
GCCTATACCTCGCTATTCCTCGACAGCCAGGTGGTCAAGTGGAACATCGAGGATGCCATC
CGCGCCTATGCCGGCGAGAAGGTCGACCCGATCAAGGACAAGCTGGACGTGCATTACCAG
CCCGGCCACCTCAAGACCGTGATGGGCGAGACGCTGGACGCCACCAACGACTGGCTGGTC
TGCCTGTCCAAGTTCTCGAAGGACCGCTTCCTGAACGTCGGGCCGCTGAAGCCGGAGAAC
GACCAGCTGATCGACATCTCGGGCGACAAGATGGTGCTGGTCCATGACGGCCCCACCTTT
GCCGAGCCGCACGACGCCATCGCCGTGCACCCCTCGATCCTGTCCGACATCAAGTCGGTC
TGGGACCGCAACGACCCGATGTGGGCCGAGACCCGCGCTCAGGCCGAGGCCGATGGCGTC
GACATCGACAACTGGACCGAAGAGGTGATCCGCGACGGCAACAAGGTGCGGGTCTACATG
TCCAGCGTGGCGCCGAGCTTCTCGATCGAGAGCTTTACCGTCAAGGAGGGCGACGAGGTC
ACGGTGATCGTCACCAACCTGGACGAGATCGACGATCTGACGCATGGCTTCACCATGGGC
AACTACGGCGTCGCCATGGAGATCGGGCCGCAGATGACCAGCTCGGTCACCTTCGTCGCC
GCCAATCCCGGGGTCTATTGGTATTATTGCCAATGGTTCTGCCATGCGCTGCACATGGAG
ATGCGCGGCCGCATGCTGGTCGAGCCGAAGGAGGCCTGA

# Drug_Target_2_General_Function:
Involved in copper ion binding

# Drug_Target_2_General_References:
10960107	Saunders NF, Hornberg JJ, Reijnders WN, Westerhoff HV, de Vries S, van Spanning RJ: The NosX and NirX proteins of Paracoccus denitrificans are functional homologues: their role in maturation of nitrous oxide reductase. J Bacteriol. 2000 Sep;182(18):5211-7.
12356332	Haltia T, Brown K, Tegoni M, Cambillau C, Saraste M, Mattila K, Djinovic-Carugo K: Crystal structure of nitrous oxide reductase from Paracoccus denitrificans at 1.6 A resolution. Biochem J. 2003 Jan 1;369(Pt 1):77-88.
8243476	Hoeren FU, Berks BC, Ferguson SJ, McCarthy JE: Sequence and expression of the gene encoding the respiratory nitrous-oxide reductase from Paracoccus denitrificans. New and conserved structural and regulatory motifs. Eur J Biochem. 1993 Nov 15;218(1):49-57.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5125

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
71414

# Drug_Target_2_Name:
Nitrous-oxide reductase

# Drug_Target_2_Number_of_Residues:
652

# Drug_Target_2_PDB_ID:
1FWX

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00116	COX2

# Drug_Target_2_Protein_Sequence:
>Nitrous-oxide reductase
MESKQEKGLSRRALLGATAGGAAVAGAFGGRLALGPAALGLGTAGVATVAGSGAALAASG
DGSVAPGQLDDYYGFWSSGQSGEMRILGIPSMRELMRVPVFNRCSATGWGQTNESVRIHE
RTMSERTKKFLAANGKRIHDNGDLHHVHMSFTEGKYDGRFLFMNDKANTRVARVRCDVMK
CDAILEIPNAKGIHGLRPQKWPRSNYVFCNGEDETPLVNDGTNMEDVANYVNVFTAVDAD
KWEVAWQVLVSGNLDNCDADYEGKWAFSTSYNSEKGMTLPEMTAAEMDHIVVFNIAEIEK
AIAAGDYQELNGVKVVDGRKEASSLFTRYIPIANNPHGCNMAPDKKHLCVAGKLSPTATV
LDVTRFDAVFYENADPRSAVVAEPELGLGPLHTAFDGRGNAYTSLFLDSQVVKWNIEDAI
RAYAGEKVDPIKDKLDVHYQPGHLKTVMGETLDATNDWLVCLSKFSKDRFLNVGPLKPEN
DQLIDISGDKMVLVHDGPTFAEPHDAIAVHPSILSDIKSVWDRNDPMWAETRAQAEADGV
DIDNWTEEVIRDGNKVRVYMSSVAPSFSIESFTVKEGDEVTVIVTNLDEIDDLTHGFTMG
NYGVAMEIGPQMTSSVTFVAANPGVYWYYCQWFCHALHMEMRGRMLVEPKEA

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-57

# Drug_Target_2_Specific_Function:
Nitrous-oxide reductase is part of a bacterial respiratory system which is activated under anaerobic conditions in the presence of nitrate or nitrous oxide

# Drug_Target_2_SwissProt_ID:
Q51705

# Drug_Target_2_SwissProt_Name:
NOSZ_PARDE

# Drug_Target_2_Synonyms:
EC 1.7.99.6
N(2)OR
N2O reductase
Nitrous-oxide reductase precursor

# Drug_Target_2_Theoretical_pI:
4.88

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03151
